ORAL MODIFIED RELEASE

Brand Owner Address Description
KARBINAL TRIS PHARMA, INC Suite D 2033 Route 130 Monmouth Junction NJ 08852 Oral modified release, extended release, and/or sustained release pharmaceutical preparations for the drug carbinoxamine, a pharmaceutically acceptable salt thereof and/or carbinoxamine polistirex, intended for the treatment of seasonal and perennial allergic rhinitis, and other approved uses;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention is concerned with controlled release compositions for oral administration comprising galantamine; and with processes of preparing such controlled release compositions.